FDA battles 'pay for delay' pharma deals; Kennedy re-files PHR incentives bill;

> The FDA is coming down hard on deals between pharma companies, known as "pay for delay," in which branded drug makers pay generic drug makers to hold off on making a generic version of their product. FiercePharma

> Rep. Patrick Kennedy (D-RI) has announced plans to re-file a bill that establishes payments of up to $3 per record for doctors whose patients establish personal health records. FierceHealthIT

> With their employers cutting benefits to keep solvent in the down economy, employees of small businesses may soon struggle to pay medical bills. Article

> Researchers have found that a mouse that makes twice the normal levels of a protein called Nrf2 is protected from Parkinson's disease. FierceBioResearcher

And Finally... What possessed this man to trap pigeons in his pants? Inquiring minds want to know. Article